COVID-19 vaccine, AstraZeneca
The Financial Express on MSN6d
AstraZeneca halts global production, sales of COVID-19 vaccine due to “surplus of available updated vaccines”In court documents from February, AstraZeneca acknowledged that Covishield can, in extremely rare instances, trigger TTS or ...
Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 ...
AstraZeneca has started to pull its Covid-19 vaccine from global markets because of low demand, the pharmaceutical giant said ...
The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled.
Eli Lilly’s and AstraZeneca’s Former Head of Research Dr. Jan Lundberg Elected as a New Board Member
STOCKHOLM, SWEDEN / ACCESSWIRE / May 15, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB, a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on Alzheimer ...
AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available ...
Colombo, May 15 (Daily Mirror) - In the wake of the recent mass withdrawal of AstraZeneca vaccines due to concerns over ...
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces that AstraZeneca has added a novel target ...
UK based drug-maker, AstraZeneca, is pulling its covid-19 vaccine from global markets due to low demand. They have been one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results